semaglutide woodbury mn Peptide Therapy in Woodbury, Semaglutide Treatment in Burnsville, MN

Wegovy is specifically FDA approved for chronic weight management in adults with obesity or who are overweight and have at least one weight-related condition, like high blood pressure or type 2 diabetes

Outcome 3: Reduces occurrences of major adverse cardiovascular events (MACE)

it is important that patients adhere to a regular injection schedule as intended

That is not the situation today

Adults with established cardiovascular disease and overweight or obesity without diabetes now have an FDA-approved indication for Wegovy (semaglutide 2.4 mg) to reduce the risk of cardiovascular death, heart attack, and stroke, based on the SELECT trial results

removing them would expose the medication to environmental contaminants and bacteria